Business Description
PDS Biotechnology Corp
NAICS : 325412
SIC : 2834
ISIN : US2798701098
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.76 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.65 | |||||
Debt-to-EBITDA | -0.59 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -13.4 | |||||
3-Year EPS without NRI Growth Rate | -16 | |||||
3-Year FCF Growth Rate | -11.5 | |||||
3-Year Book Growth Rate | -13.5 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.46 | |||||
9-Day RSI | 43.2 | |||||
14-Day RSI | 44.49 | |||||
6-1 Month Momentum % | -50.31 | |||||
12-1 Month Momentum % | -59.05 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.56 | |||||
Quick Ratio | 4.56 | |||||
Cash Ratio | 4.42 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.1 | |||||
Shareholder Yield % | -29.94 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -136.07 | |||||
ROA % | -69.05 | |||||
ROIC % | -1093.71 | |||||
ROC (Joel Greenblatt) % | -10854.49 | |||||
ROCE % | -76.29 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.33 | |||||
Price-to-Tangible-Book | 3.18 | |||||
EV-to-EBIT | -1.76 | |||||
EV-to-Forward-EBIT | -1.47 | |||||
EV-to-EBITDA | -1.76 | |||||
EV-to-Forward-EBITDA | -1.47 | |||||
EV-to-Forward-Revenue | 2.76 | |||||
EV-to-FCF | -2.68 | |||||
Price-to-Net-Current-Asset-Value | 3.18 | |||||
Price-to-Net-Cash | 3.39 | |||||
Earnings Yield (Greenblatt) % | -56.76 | |||||
FCF Yield % | -26.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PDS Biotechnology Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.267 | ||
Beta | 1.63 | ||
Volatility % | 78.53 | ||
14-Day RSI | 44.49 | ||
14-Day ATR (€) | 0.141672 | ||
20-Day SMA (€) | 3.2698 | ||
12-1 Month Momentum % | -59.05 | ||
52-Week Range (€) | 2.456 - 9.15 | ||
Shares Outstanding (Mil) | 36.68 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PDS Biotechnology Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PDS Biotechnology Corp Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
PDS Biotechnology Corp Frequently Asked Questions
What is PDS Biotechnology Corp(FRA:EU6)'s stock price today?
When is next earnings date of PDS Biotechnology Corp(FRA:EU6)?
Does PDS Biotechnology Corp(FRA:EU6) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |